Orasis Pharms Drug Patent Portfolio
Orasis Pharms owns 1 orange book drug protected by 4 US patents Given below is the list of Orasis Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10639297 | Ophthalmic pharmaceutical compositions and uses relating thereto | 18 Aug, 2037 | Active |
| US11129812 | Ophthalmic pharmaceutical compositions and uses relating thereto | 18 Aug, 2037 | Active |
| US11974986 | Ophthalmic pharmaceutical compositions and uses relating thereto | 18 Aug, 2037 | Active |
| US9867810 | Ophthalmic pharmaceutical compositions and uses relating thereto | 18 Aug, 2037 | Active |
Latest Legal Activities on Orasis Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Orasis Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Oct, 2023 | US10639297 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Sep, 2021 | US11129812 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Sep, 2021 | US11129812 |
|
Email Notification
Critical
| 09 Sep, 2021 | US11129812 |
|
Issue Notification Mailed
Critical
| 08 Sep, 2021 | US11129812 |
|
Application Is Considered Ready for Issue
Critical
| 25 Aug, 2021 | US11129812 |
| Dispatch to FDC | 25 Aug, 2021 | US11129812 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 24 Aug, 2021 | US11129812 |
|
Email Notification
Critical
| 24 Aug, 2021 | US11129812 |
|
Response to Amendment under Rule 312
Critical
| 19 Aug, 2021 | US11129812 |
|
Amendment after Notice of Allowance (Rule 312)
Critical
| 18 Aug, 2021 | US11129812 |
| Mail PUB other miscellaneous communication to applicant | 11 Aug, 2021 | US11129812 |
|
Email Notification
Critical
| 11 Aug, 2021 | US11129812 |
| PUB Other miscellaneous communication to applicant | 09 Aug, 2021 | US11129812 |
|
Issue Fee Payment Verified
Critical
| 27 Jul, 2021 | US11129812 |
Orasis Pharms's Family Patents
Orasis Pharms Drug List
Given below is the complete list of Orasis Pharms's drugs and the patents protecting them.
1. Qlosi
Qlosi is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10639297 | Ophthalmic pharmaceutical compositions and uses relating thereto |
18 Aug, 2037
(12 years from now)
| Active |
| US11129812 | Ophthalmic pharmaceutical compositions and uses relating thereto |
18 Aug, 2037
(12 years from now)
| Active |
| US11974986 | Ophthalmic pharmaceutical compositions and uses relating thereto |
18 Aug, 2037
(12 years from now)
| Active |
| US9867810 | Ophthalmic pharmaceutical compositions and uses relating thereto |
18 Aug, 2037
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qlosi's drug page